CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-03 | OYLER JOHN Chief Executive Officer | Sale | −2,876 | $220.42 | $634K | 21,394 |
| 2020-08-03 | OYLER JOHN Chief Executive Officer | Sale | −12,020 | $221.43 | $2.7M | 9,374 |
| 2020-08-03 | OYLER JOHN Chief Executive Officer | Sale | −3,567 | $222.14 | $792K | 5,807 |
| 2020-08-03 | OYLER JOHN Chief Executive Officer | Sale | −3,107 | $223.46 | $694K | 2,700 |
| 2020-08-03 | OYLER JOHN Chief Executive Officer | Sale | −2,400 | $224.23 | $538K | 300 |
| 2020-08-03 | OYLER JOHN Chief Executive Officer | Sale | −300 | $225.08 | $68K | 0 |
| 2020-07-29 | Huang Jane CMO, Hematology | Option exercise | +1,500 | $29.49 | $44K | 1,500 |
| 2020-07-29 | Huang Jane CMO, Hematology | Option exercise | +1,500 | $160.40 | $241K | 3,000 |
| 2020-07-29 | Huang Jane CMO, Hematology | Sale | −1,301 | $208.35 | $271K | 1,699 |
| 2020-07-29 | Huang Jane CMO, Hematology | Sale | −700 | $208.91 | $146K | 999 |
| 2020-07-29 | Huang Jane CMO, Hematology | Sale | −200 | $211.31 | $42K | 799 |
| 2020-07-29 | Huang Jane CMO, Hematology | Sale | −400 | $212.53 | $85K | 399 |
| 2020-07-29 | Huang Jane CMO, Hematology | Sale | −399 | $213.56 | $85K | 0 |
| 2020-07-29 | Huang Jane CMO, Hematology | Option exercise · Share Option (Right to Buy) | −19,500 | 441,575 | ||
| 2020-07-29 | Huang Jane CMO, Hematology | Option exercise · Share Option (Right to Buy) | −19,500 | 212,680 | ||
| 2020-07-22 | OYLER JOHN Chief Executive Officer | Sale | −6,136 | $235.26 | $1.4M | 21,612 |
| 2020-07-22 | OYLER JOHN Chief Executive Officer | Sale | −4,200 | $236.14 | $992K | 17,412 |
| 2020-07-22 | OYLER JOHN Chief Executive Officer | Sale | −4,612 | $237.61 | $1.1M | 12,800 |
| 2020-07-22 | OYLER JOHN Chief Executive Officer | Sale | −3,300 | $238.54 | $787K | 9,500 |
| 2020-07-22 | OYLER JOHN Chief Executive Officer | Sale | −2,400 | $239.45 | $575K | 7,100 |
Page 87 of 99 · 1,972 trades